International Clinical Trial: A Multimodal AI-based Intelligent System for Screening and Risk Stratification of Sarcopenia

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119436) titled 'A Multimodal AI-based Intelligent System for Screening and Risk Stratification of Sarcopenia' on Feb. 27.

Study Type: Diagnostic test

Study Design: Case-Control study

Primary Sponsor: Beijing Chao-Yang Hospital, Capital Medical University

Condition: Sarcopenia

Intervention: Gold Standard:The Asian Working Group for Sarcopenia (AWGS) consensus was adopted as the "gold standard" for diagnosing sarcopenia. Muscle strength: Dominant handgrip strength was measured using an electronic dynamometer. Muscle mass: Appendicular skeletal muscle mass was measured by bioelectrical impedance analysis (BIA).

Recruitment...